Trump Announces Historic Prescription Drug Price Cuts Ahead Of Midterms

President Donald Trump announced that lowering prescription drug prices will be a key issue in the upcoming midterm elections, calling the cuts a “shock to the system” that will help millions of Americans.

He revealed that Pfizer will now allow state Medicaid programs to purchase medications at the lowest international prices, known as most-favored-nation (MFN) rates.

According to the White House, several major drugs will see deep discounts — including Eucrisa, reduced by 80 percent, Xeljanz by 40 percent, and Zavzpret by 50 percent. Trump described the initiative as the start of a broader push to make medications more affordable.

“We’re going to show you some incredible drops in prices — numbers never seen before,” Trump told reporters, promising additional announcements in the coming weeks.

Asked how much this could influence the midterm elections, Trump called the impact “huge,” noting that his administration had planned these reforms earlier but shifted focus to the COVID-19 pandemic. He pointed to his previous collaboration with pharmaceutical leaders as proof of his ability to drive change.

Trump emphasized that reducing drug costs has been a major focus of his administration for the past eight months, saying the MFN policy will ensure Americans pay the same prices as other nations. “Those days of being ripped off are over,” he said.

Meanwhile, Trump’s approval rating has risen sharply. Rasmussen Reports found that 53 percent of likely U.S. voters now approve of his performance — a 10-point swing upward in just a few days.